Research progress of azacitidine in the treatment of elderly patients with acute myeloid leukemia
10.3760/cma.j.issn.1009-9921.2016.05.016
- VernacularTitle:阿扎胞苷治疗老年人急性髓系白血病的研究进展
- Author:
Ruifang WANG
;
Lijuan RU
- Publication Type:Journal Article
- Keywords:
Leukemia,myeloid,acute;
Elderly;
Hypomethylation;
Azacitidine
- From:
Journal of Leukemia & Lymphoma
2016;25(5):312-314
- CountryChina
- Language:Chinese
-
Abstract:
Azacitidine belongs to a novel family of demethylation antitumor drug.Foreign clinical researches have demonstrated that it may be a low toxic and effective choice for elderly patients with acute myeloid leukemia,whose physical conditions are too poor to sustain intensive chemotherapy.This review will summarize recent reports on azacitidine in the treatment of elderly patients with acute myeloid leukemia.
